Freeport-McMoRan, Inc. vs Sherwin-Williams Company (The) — Stock Comparison
Q·Score Breakdown
8.4
Buy
Overall
6.4
Hold
Quality
Health
Growth
Valuation
Sentiment
FCX
Clean balance sheet with low leverage (0.3× debt-to-equity).
SHW
High-quality business with 61% return on equity and 11% profit margins.
⚠ high leverage at 3.3× debt-to-equity.
Analyst Consensus
BUY
Target $67.90 (+18.3%)
21 analysts
BUY
Target $377.95 (+17.2%)
21 analysts
Fundamentals
FCX
SHW
30.4×
Trailing P/E
30.9×
15.5×
Forward P/E
24.2×
10.3%
Profit Margin
10.9%
37.1%
Gross Margin
49.0%
15.6%
ROE
60.7%
8.8%
Revenue Growth
6.8%
154.0%
Earnings Growth
7.5%
1.47
Beta
1.27
—
Price / Book
—
$82.4B
Market Cap
$79.6B
$35 – $71
52-Week Range
$302 – $380
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.